Microlyte® Surgical is a sterile, single-use absorbent polymeric surgical matrix composed primarily of bioresorbable polyvinyl alcohol with a polymeric surface coating containing ionic and metallic silver.
• Absorbs wound fluid and transforms into a soft, bioresorbable material that intimately contours to the underlying surgical wound bed
• Contains antimicrobial silver which kills bacteria in contact with the matrix that can cause surgical site infection (SSI)
• Low residual toxicity compared to other antimicrobial matrices
Under the supervision of a health care professional, Microlyte® Surgical may be used for the management of:
• Partial- and full-thickness wounds including pressure injuries, venous stasis ulcers, diabetic ulcers, first- and second-degree burns, abrasions and lacerations, donor sites and surgical wounds
• May be used over debrided and grafted partial-thickness wounds
Do not use on individuals who are sensitive to silver or who have had an allergic reaction to Microlyte® Surgical or one of its components.
• Warning: Frequent or prolonged use of this product may result in permanent discoloration of skin
• Warning: Avoid use with iodophore containing products that may reduce the effectiveness of silver in the dressing
• The wound should be inspected during cover dressing changes. Consult a health care professional if you see (a) signs of infection (increased pain, increased redness, wound drainage), (b) bleeding, (c) a change in wound color and/or odor, (d) irritation (increased redness and/or inflammation), (e) maceration (skin whitening), (f) hyper-granulation (excessive tissue formation), (g) sensitivity (allergic reaction), (h) no signs of healing
• Microlyte® Surgical should not be used with other wound care products other than those listed in the “Directions For Use” section without first consulting a health care professional.
• This product contains <0.5 mg/in2 polyethylene glycol (400 Da).
Store at room temperature (15°C-30°C, 59°F-86°F). Keep dry. If further information is needed, please contact Imbed Biosciences, Inc.
Ionic and metallic silver
Polyvinyl alcohol (99%), proprietary polyvinyl electrolytes (<1%)
|Biosynthetic - animal-based|
|Indicated for chronic vascular ulcers|
|Indicated for diabetic ulcers|
|Indicated for draining wounds|
|Indicated for partial- and full-thickness wounds||●|
|Indicated for pressure ulcers|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for trauma wounds||●|
|Indicated for venous ulcers|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
• Clean the wound area using sterile saline solution.
• If the wound is dry, moisten it with sterile saline and remove excess saline with sterile gauze.
• Avoid contact with wet surfaces until placed on a moist wound bed.
• Cut Microlyte® Surgical to size slightly larger than the wound. Multiple sheets can be used to tile the entire wound area.
• Apply Microlyte® Surgical directly to wound bed. When placed on a moist wound bed, the dressing forms a soft conforming sheet.
• Microlyte® Surgical should be used with a secondary cover dressing. Cover with a moisture retentive dressing such as a film dressing, foam dressing, wet-to-dry gauze or other appropriate dressing. See individual cover dressing package inserts for complete instructions for use. All dressing site areas should be inspected daily.
• Reapply Microlyte® Surgical daily or up to every three days, depending on the wound and the healing progression, or when clinically indicated (e.g., leakage, excessive bleeding, increased pain).
• To reapply, carefully remove the secondary cover dressing. Gently irrigate wound with sterile saline to remove necrotic tissue. It is not necessary to remove any residual Microlyte® Surgical observed during secondary cover dressing changes.
• Change the secondary cover dressing as needed or when Microlyte® Surgical is re-applied.
• Duration of treatment depends on wound type and healing conditions.
Imbed Biosciences is a privately held medical device company developing next-generation medical devices for the management of burns, chronic ulcers, gastrointestinal defects and soft-tissue repair.